These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27799398)

  • 21. Diagnostic criteria for idiopathic pulmonary fibrosis.
    Fidler L; Shapera S
    Lancet Respir Med; 2018 Feb; 6(2):e6. PubMed ID: 29413089
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic criteria for idiopathic pulmonary fibrosis.
    Santos MK; Fabro AT; Baddini-Martinez J
    Lancet Respir Med; 2018 Feb; 6(2):e5. PubMed ID: 29413088
    [No Abstract]   [Full Text] [Related]  

  • 23. Patient-reported outcome measures in idiopathic pulmonary fibrosis: Where do we stand?
    Canu S; Alfieri V; Renzoni E
    Respirology; 2017 May; 22(4):628-629. PubMed ID: 28328170
    [No Abstract]   [Full Text] [Related]  

  • 24. Toward understanding patient experience in idiopathic pulmonary fibrosis.
    Danoff SK
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28100552
    [No Abstract]   [Full Text] [Related]  

  • 25. Taking a giant step in the diagnosis of idiopathic pulmonary fibrosis.
    Tzilas V; Valeyre D; Tzouvelekis A; Bouros D
    Lancet Respir Med; 2018 Feb; 6(2):82-84. PubMed ID: 29154105
    [No Abstract]   [Full Text] [Related]  

  • 26. It takes a village to care for the patient with idiopathic pulmonary fibrosis.
    Fischer A
    Cleve Clin J Med; 2018 May; 85(5):387-389. PubMed ID: 29733780
    [No Abstract]   [Full Text] [Related]  

  • 27. Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease.
    Hutchinson J
    Eur Respir J; 2016 Jul; 48(1):26-8. PubMed ID: 27365508
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemiology, survival, incidence and prevalence of idiopathic pulmonary fibrosis in the USA and Canada.
    Raghu G
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28122859
    [No Abstract]   [Full Text] [Related]  

  • 29. Epidemiology, survival, incidence and prevalence of idiopathic pulmonary fibrosis in the USA and Canada.
    Harari S; Caminati A; Madotto F; Conti S; Cesana G
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28122864
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy for idiopathic pulmonary fibrosis: lessons from pooled data analyses.
    Troy LK; Corte TJ
    Eur Respir J; 2016 Jan; 47(1):27-30. PubMed ID: 26721960
    [No Abstract]   [Full Text] [Related]  

  • 31. European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity.
    Bonella F; Wijsenbeek M; Molina-Molina M; Duck A; Mele R; Geissler K; Wuyts W
    Eur Respir J; 2016 Jul; 48(1):283-4. PubMed ID: 27365516
    [No Abstract]   [Full Text] [Related]  

  • 32. European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity.
    Bush A; Barbato A; Clement A; Cunningham S; Blic Jd; Gilbert C; Goldbeck L; Kiper N; Schwerk N; Griese M
    Eur Respir J; 2016 Jul; 48(1):282-3. PubMed ID: 27365515
    [No Abstract]   [Full Text] [Related]  

  • 33. Predicting the future of patients with idiopathic pulmonary fibrosis: another step forward.
    Luppi F
    Lancet Respir Med; 2017 Dec; 5(12):911-913. PubMed ID: 29150408
    [No Abstract]   [Full Text] [Related]  

  • 34. Host-Microbial Interactions: Idiopathic Pulmonary Fibrosis in Technicolor.
    O'Dwyer DN; Habiel D; Hogaboam C
    Am J Respir Crit Care Med; 2017 Jun; 195(12):1554-1556. PubMed ID: 28617080
    [No Abstract]   [Full Text] [Related]  

  • 35. Central pulmonary arteries in idiopathic pulmonary fibrosis: size really matters.
    Price LC; Devaraj A; Wort SJ
    Eur Respir J; 2016 May; 47(5):1318-20. PubMed ID: 27132263
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies.
    Richeldi L; Wilson KC; Raghu G
    Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30190265
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute exacerbations of idiopathic pulmonary fibrosis: tough to define; tougher to manage.
    Hambly N; Cox G; Kolb M
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28526803
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic criteria for idiopathic pulmonary fibrosis - Authors' reply.
    Lynch DA; Sverzellati N; Travis WD; Colby TV; Inoue Y; Nicholson AG; Raoof S; Richeldi L; Ryerson CJ; Ryu JH
    Lancet Respir Med; 2018 Feb; 6(2):e7. PubMed ID: 29413090
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeted treatment of idiopathic pulmonary fibrosis: one step at a time.
    Richeldi L
    Eur Respir J; 2016 May; 47(5):1321-3. PubMed ID: 27132264
    [No Abstract]   [Full Text] [Related]  

  • 40. Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management.
    Baldi BG
    J Bras Pneumol; 2017; 43(6):401-402. PubMed ID: 29340483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.